Interim strategic guidance document

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Myriam Drysdale, Marianne Cunningham and Bart Barefoot(GlaxoSmithKline); Fredrik Moen from the Swedish Institute of Health; Tino Melzer (Bayer); Irene Schluender (TMF);Michel Van Speybroeck (Janssen); Michael Arend (Bayer); Jeremy Hayter (Pfizer); Joachim Marti (Imperial College London); Anthony Rowe (Janssen);Jerry Lanfear (Pfizer);Carmen Fenollosa (LSE);László Bencze (Semmelweis University)

Journal publisher: BD4BO Programme

Published year: 2017